According to Benitec Biopharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1212.76. At the end of 2023 the company had a P/S ratio of 136.
Year | P/S ratio | Change |
---|---|---|
2023 | 136 | 77.54% |
2022 | 76.7 | -89.97% |
2021 | 765 | 154.56% |
2020 | 300 | |
2018 | > 1000 | 9.21% |
2017 | > 1000 | 9.55% |
2016 | > 1000 | -17.57% |
2015 | > 1000 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
NRC Health
NRC | 5.62 | -99.54% | ๐บ๐ธ USA |